• VueWay is a gadolinium-based contrast agent indicated in adult and pediatric patients aged 2 years and older for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in:

? the central nervous system (brain, spine, and associated tissues),
? the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system).

The post BRACCO VUEWAY 10ML VIAL 10/BX 703042 appeared first on SpectrumXray.

ProHance (Gadoteridol) Injection, 279.3 mg/mL provides macrocyclic GBCA stability, along with proven efficacy. The TRUTH study showed no significant difference in detection and characterization of central nervous system (CNS) lesions with ProHance^® (Gadoteridol) when compared to Gadavist^®. In addition, no difference was found by any reader for any of the 5 qualitative image evaluation endpoints:³

• Global diagnostic preference
• Lesion border delineation
• Definition of disease extent
• Visualization of lesion internal morphology
• Lesion contrast enhancement

ProHance provided improved delineation and enhancement of primary and secondary neoplastic lesions of the brain and spine in children.⁴ In a multicenter clinical trial of 103 children, 60% of scans were enhanced, and 30-95% of scans resulted in additional diagnostic information.¹

The post BRACCO PROHANCE 17ML PFS 5/BOX appeared first on SpectrumXray.

The post BRACCO PROHANCE 10ML PREFS 5/BOX appeared first on SpectrumXray.

The post CLARISCAN INJECTION 15mL 0.5mm appeared first on SpectrumXray.

• Clariscan 0.5 mmol/mL is a sterile, clear, colorless to yellow, aqueous solution for intravenous injection containing 376.9 mg/mL gadoterate meglumine.
• Glass vial: Aseptically draw up the contrast medium into a disposable syringe and use immediately.
• To ensure complete injection of Clariscan, the injection may be followed by normal saline flush. Contrast MRI can begin immediately following Clariscan injection.
• Visually inspect Clariscan for particulate matter prior to administration. Do not use the solution if particulate matter is present or if the container appears damaged. Clariscan should be a clear, colorless to yellow solution.
• Do not mix with other drugs or parenteral nutrition.
• Discard any unused portions of the drug.

The post Clariscan Injection 10mL 0.5mm – Precise MRI Contrast Enhancement for Accurate Diagnostics appeared first on SpectrumXray.

• Clariscan 0.5 mmol/mL is a sterile, clear, colorless to yellow, aqueous solution for intravenous injection containing 376.9 mg/mL gadoterate meglumine.
• Glass vial: Aseptically draw up the contrast medium into a disposable syringe and use immediately.
• To ensure complete injection of Clariscan, the injection may be followed by normal saline flush. Contrast MRI can begin immediately following Clariscan injection.
• Visually inspect Clariscan for particulate matter prior to administration. Do not use the solution if particulate matter is present or if the container appears damaged. Clariscan should be a clear, colorless to yellow solution.
• Do not mix with other drugs or parenteral nutrition.
• Discard any unused portions of the drug.

The post CLARISCAN INJECTION 5mL 0.5mmo appeared first on SpectrumXray.

• Clariscan 0.5 mmol/mL is a sterile, clear, colorless to yellow, aqueous solution for intravenous injection containing 376.9 mg/mL gadoterate meglumine.
• Glass vial: Aseptically draw up the contrast medium into a disposable syringe and use immediately.
• To ensure complete injection of Clariscan, the injection may be followed by normal saline flush. Contrast MRI can begin immediately following Clariscan injection.
• Visually inspect Clariscan for particulate matter prior to administration. Do not use the solution if particulate matter is present or if the container appears damaged. Clariscan should be a clear, colorless to yellow solution.
• Do not mix with other drugs or parenteral nutrition.
• Discard any unused portions of the drug.

The post CLARISCAN INJECTION 20mL 0.5mm appeared first on SpectrumXray.

• The central nervous system (brain, spine, and associated tissues).
• The body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system).

The post BRACCO VUEWAY 3ML VIAL 10/BX appeared first on SpectrumXray.

The post Bracco ProHance 10mL Vial 5/BX: Advanced MRI Contrast Solution for Clear Imaging appeared first on SpectrumXray.

The post BRACCO PROHANCE 15ML VIAL 5/BX appeared first on SpectrumXray.